• 2022

  2021 Outstanding Industrial Contribution Award for China Listed Companies

  2021 Evergreen Award Innovative Pharmaceutical Company of the Year

  Rapilin^® and Rapilin^®30 Awarded the honorary recognition of Beijing New Technology and New Products

  2021 Beijing Enterprise Innovation Credit Leader

  AAA grade credit enterprise in pharmaceutical industry in 2021

  Basalin^® wins 2021-2022 Best Selling Brand of the Year in the Pharmaceutical Retail Market

  Top 20 biopharmaceutical (including blood, vaccine, insulin, etc.) companies in China in 2021

  Dr. Gan Zhongyu was awarded the 14th

  Health China - Top 10 Pharmaceutical Industry Figures

  Dr. Wei Chen was listed on “the 36 2022 Krypton Global Chinese Elite power 100 list”

  Gan & Lee Pharmaceuticals wins again China Pharmaceutical Industry Top 100 Honors

  Top 100 Beijing Private Enterprises in” Science and Technology” “Innovation and Social Responsibility “for 2022

  CEO Kai Du was listed in the “2022 outstanding returnees“ 100 list

  Pharmaceutical and Biological Industry Track Winners Award

• 2021

  Awarded with the title "Forbes China's Most Innovative Employer of Human Resource Management"

  Won the "13th Five-Year Plan" Enterprise Management Award for "Growth Outstanding Enterprise"

  Insulin Aspart Injection was named as "Breakthrough Drug of the Year"

  Selected as one of the 2021 Top50 emerging brands of list companies in China

• 2020

  Selected as "Chinese Chemical Pharmaceutical Industry Comperhensive Strength Top 100 Industrial Enterprises in 2020"

  The title of "Top 10 Value Investment in Pharmaceutical and Biological Industry" of Golden Wisdom Award

  Certified as the 2020 best Innovative Growth Enterprise in the Biotech Industry Annual List

  Golden Bauhinia Award——The honor for a Listed Company with the Strongest Sense of Corporate Responsibility

• 2019

  Won the 2019 China Chemical and Pharmaceutial Industry Environmental Protection, Green Pharmaceutial Special Award

• 2018

  Recombinant insulin glargine injection won the 1st prize of science and techonology of Chinese Pharmaceitical Association

• 2017

  Won the National High-tech Enterprise Certificate

• 2016

  Awarded with the title "China's Top 10 Most Innovative Pharmaceutical Companies with Potential"

• 2015

  Glargine (Basalin^®) Received significant support as one of the national"Three Key Projects"

• 2012

  Awarded with the title "Forbes China's Most Promising Unlisted Companies"

• 2013

  "Molecular Chapterone Technology" won China Invention Patent Gold Award

  Glargine (Basalin^®)became a biomedicine major category supported by the national major scientific and technological special project for "Significant New Drugs Development" during the "12th Five-Year Plan" period

• 2011

  Named in Deloitte's 2011 "Fortune 50, High Technology and High Growth Enterprises" list

  Glargine (Basalin^®)became a biomedicine major category supported by the national major scientific and technological special project for "Significant New Drugs Development" during the "11th Five-Year Plan" period

  Won the "2011 China's Healthcare Industry-Most Investment Value Enterprise TOP 100"

  Selected to participate in the Great Development Project of Beijing Biopharmaceutial Industry(the g20 pROJECT),and won the title of "Large Scale Enterprise"

• 2009

  Obtained the Certificate of Beijing High and New Techonology Achievement Conversion Project

For more information, please visit our CN website.